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Background: The aim of this study was to investigate the inﬂuence of a combined supplementation with magne-
sium, selenium and coenzyme Q10 on the morphology of the thyroid in patients with benign diseases. The clin-
ical examination and treatment approach aims additionally at treating musculoskeletal and psychological stress.
Methods: A group of 8 patients (5 with hyperthyroidism, 3 with hypothyroidism)who initially attended a public
institution received additional treatment at our private institution. The basic pharmacological treatment, i.e. sub-
stitution or thyreostatic, was kept unchanged. The inclusion of patients required good quality ultrasound images
to be available.
Results: Initially the changes of the musculoskeletal system were corrected. Following this, stress components
were also treated. After a period of 2–4 years of supplementation we observed a normalization of thyroid mor-
phology as evidenced on ultrasoundwhile at the same time therewas a reduction of perfusion intensity. Thyroid
antibody titers decreased in themajority of cases. Failure of the treatment was seen in 2 cases of chronic thyroid-
itis that was present for more than 10 years. The ultrasound images of these patients suggest a possible ﬁbrosis.
Conclusions: In spite of the limitation due to the small number of cases, our observational study has delivered
proof of concept for our examination and treatment model for benign thyroid disease.
General signiﬁcance: Our results challenge validity of the prevailing dogma of a destructive unstoppable
“autoimmune” destructive process of the gland. At the same time it shows new therapeutic options for patients
with thyroid disease.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
More than 100 years ago Haraku Hashimoto presented the results of
a histological examination of 4 cases of the so-called struma-
lymphomatosa [1], a condition that is now known as Hashimoto's thy-
roiditis. While H. Hashimoto could not offer an explanation for the
changes involved, 100 years later Caturegli and coworkers appear to
share the same state-of-the-art by stating: “… still incompletely deﬁned
etiopathogenesis” (paragraph 1 in [2]). In daily practice ultrasound ex-
amination is one easily available method for the visualization of the
changes associatedwith Hashimoto's thyroiditis. In a recent publicationonine; TSH, thyroid stimulating
, anti-TSH receptor antibodies;
asse 5, 6020 Innsbruck, Austria.
o).
. This is an open access article underChaudhary and Bano enumerate the characteristic changes seen in
Hashimoto's thyroiditis as well as in autoimmune hyperthyroidism:
the typical image will show a heterogeneous hypo-echogenicity. The
changes in both diseases can sometimes be indistinguishable [3]. The
etiopathogenesis, i.e. the cause and development of a disease or an ab-
normal condition,1 of these benign thyroid diseases has been attributed
to a dogmatic construct called autoimmunity whichwas initiated in the
1950s [4]. At the present time this dogma does not provide any thera-
peutic alternative and it is generally accepted that the end-stage situa-
tion will be the destruction of thyroid tissue.
Our own investigations on the etiopathogenesis of thyroid diseases
have relied on a different methodology as immunologists have. In a
ﬁrst stage we described a relation of hyperthyroidism to alterations of
the musculoskeletal system which went together with changes in the
correlation between magnesium and calcium levels [5]. In another
study we described the sub-optimal levels of selenium in patients
with thyroid disease [6]. Recently, in 2014,we have been able to disclose1 http://www.merriam-webster.com/medical/etiopathogenesis.
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. A. HM. Female patient with hyperthyroidism. Sequential ultrasound images made with the Siemens Antares machine. B: Current ultrasound image (2014) conﬁrms normal
morphology.
114 R. Moncayo, H. Moncayo / BBA Clinical 3 (2015) 113–122a condition of magnesium deﬁciency that is a common denominator of
hypothyroidism [7] as well as of hyperthyroidism [8]. The main events
that correlate with this condition of magnesium deﬁciency are physicaland psychological stressors. The introduction of new concepts in the
medical ﬁeld requires a proof of plausibility in order to be accepted.
Proof of concept should provide clinical conﬁrmation of a desired effect
AB
Fig. 2. A. KC. Hyperthyroidism showing partial recovery. Sequential ultrasound images made with the Siemens Antares machine. B: Current ultrasound image (2014) showing partial re-
covery of morphology. Hyperperfusion is no longer present.
115R. Moncayo, H. Moncayo / BBA Clinical 3 (2015) 113–122in patientswith a speciﬁc disease. In a recent articleWong et al. handled
the options of relying on an imaging method for this purpose [9]. The
authors mention the following processes: “(1) early clinical experi-
ments that are designed to demonstrate ‘proof of biology’ by testing anovel hypothesis that link target engagement (TE) to drug-induced bio-
logical changes expected to give clinical beneﬁt and (2) subsequent
clinical experiments that demonstrate proof of concept (PoC), i.e. en-
gaging a particular target is linked to a meaningful change in a clinical
Fig. 3.A. BM. Patient with hypothyroidism showing recovery after takingmagnesium, selenium and coenzyme Q10. In August 2013 the patient was pregnant and thyroidmedication was
started after the TSH level had risen. At this time, however, fT4 levels were sufﬁcient. Sequential ultrasound images made with the Siemens Antares machine.
Fig. 4. KS. Hyperthyroidism in a womanwith psychological stressors due to a divorce process min 2012–2014. The drop in magnesium in September 2014 was related to work overload.
Sequential ultrasound images made with the Siemens Antares machine.
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AB
Fig. 5. A. RN. Hyperthyroidism and subsequent uneventful pregnancy. Sequential ultrasound imagesmadewith the Siemens Antares machine. B: Current ultrasound image (2014) show-
ing partial recovery of morphology.
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tients.” Following these lines of thought this study was conceived to
bring a proof of concept of theWOMEDmodel of benign thyroid disease.
Our therapy concept includes the correction ofmusculoskeletal changesas well as treatment of psychological stress together with magnesium
and selenium supplementation. The null hypothesis stated that no
changes in thyroid morphology as seen in sonographic examinations
could be expected to occur following treatment.
Fig. 6. LB. Quite heterogeneous ultrasound pattern initially. Correction with magnesium, selenium and coenzyme Q10. Sequential ultrasound images made with the Siemens Antares
machine.
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We selected a series of 8 female patients initially attending a pub-
lic institution. Five patients had hyperthyroidism and three had hy-
pothyroidism. The patients were seen between 2008 and 2014. The
age of the patients was between 24 and 39 years. In addition to the
standard medical care provided at the public institution the subjects
were also examined and treated at our private institution following
the wish of the patients (WOMED, Innsbruck, Austria). All proce-
dures were done in accordance with the Declaration of Helsinki
[10]. The term “The WOMED Model” refers to a combination of
examination, diagnostic and therapeutical methods used routinely
by us [7].
2.1. Standard and advanced thyroid sonography
The main objective indicator in this study was the sonographic eval-
uation of thyroid morphology. In the ﬁrst place routine sonography
evaluations were done using the Siemens Sonoline Antares machine
using the VFX 13-5 transducer (Siemens AG, Erlangen, Germany).
Advanced quantitative 3D-power Doppler sonography was done using
a Voluson Pro machine and the VOCAL software [11]. Recent follow-up
examinations in December 2014 were done with a Toshiba Xario 200
machine with the 14L5 probe. Color Doppler was done in the Advanced
Dynamic Flow®mode [12,13]. All sonography studies were done by the
same investigator (RM).2.2. Clinical examination and treatment approach
The principle of the clinical examination is to search for changes of
the musculoskeletal system. These can be lateral tension, idiopathic
moving toes and blockade of pelvic motion during inspiration [5,7,14].
When the subjects present these conditions a supplementation with
magnesium is started. The preferred pharmacological form is puremag-
nesium citrate at a dose of 3 to 4 times 1.4 mmol per day in divided
takes. After an initial period of 4 to 6 weeks manual medicine methods
as well as acupuncture are then used to correct the alterations [7]. Psy-
chological stress is investigated at the same time. Using a previously de-
scribed method the inﬂuence of stressors is investigated and treated
[15]. This treatment requires 3 to 4 sessions. Magnesium supplementa-
tion was maintained over a period of at least 4 years.
Thyroid hormones which have been prescribed previously were
continued in the same dosage. Anti-thyroid medicationwas tapered ac-
cording to the routine laboratory results.3. Results
The initial sonography studies presented the characteristic inhomo-
geneous hypo-echogenic pattern. During supplementation and treat-
ment of stressors we observed a restitution of thyroid morphology.
This recovery took between 3 and 4 years. At the same time the initially
increased vascularity diminished. During the time of magnesium
119R. Moncayo, H. Moncayo / BBA Clinical 3 (2015) 113–122supplementation blood levels of magnesium showed variations. These
changeswere correlated to previously identiﬁed psychological stressors
(term examinations, unusual work load, divorce process, evening
school).
Two of the cases presented were seen in relation to pregnancy. In
the ﬁrst case the initial TSH value was 17.2 mIU/L. This value
dropped to 4.1 under magnesium supplementation. At this time
pregnancy was detected and had an uneventful course. Late in preg-
nancy, 8th month, TSH rose again and thyroid medication was given.
In the second case the initial TSH value was 16 mIU/L and dropped to
2.8 after starting on magnesium. In the subsequent months a preg-
nancy was detected and a healthy normal child was delivered. Thy-
roid medication was not given at any time. The graphical results
are presented in Figs. 1–8.
In one case of hypothyroidism with underlying coenzyme Q10 deﬁ-
ciency, hypervascularization could be corrected by means of combined
supplementation with magnesium, selenium, and coenzyme Q10 dur-
ing 3 months. In the last 3 months a Western herb compound was
added. In short, the compound includes Ruta graveolens, Anemone
pulsatilla, Hypericum perforatum, Serenoa serrulata, Schisandra chinensis,
Ophiopogon japonicus, Glycyrrhiza glabra and Zingiber ofﬁcinale [16]. The
theoretical action mode of this multi-agent compound has been de-
scribed elsewhere [17].
The use of color Doppler in the AdvancedDynamic Flow®mode pro-
vided images that better delineate the vascular structures within the
thyroid.Fig. 7. SK. Hypothyroidism corrected by magnesiuA special perfusion pattern was observed in cases with suspected
low levels of coenzyme Q10 (Fig. 9). In such a situation wide vessels
were visible. This combination was observed in other patients not
shown here.
In two patients with thyroiditis the implementation of supplemen-
tation did not lead to any improvement of thyroidmorphology (Fig. 10).
4. Discussion
This observational study demonstrates the recovery of thyroid mor-
phology as seen on sonography after treating patients according to the
principles of the WOMED model of thyroid disease. This approach ex-
pands the usual therapeutical measures used in thyroid disease and it
applies both to patients with Grave's disease as well as to patients
with Hashimoto's disease. The addition of 3D-power Doppler tech-
niques has allowed us to identify patients who show characteristics of
“thickened vessels” which appear to be related to low levels of coen-
zyme Q10. Two patients who did not respond to supplementation
presented imaging data suggestive of ﬁbrosis which can be found in
the ﬁbrous variant of thyroiditis [18,19].
The apparent limitation of the study due to a small number of pa-
tients has to be viewed as a relative issue. In this account we have de-
scribed patients who were initially attending a public hospital. In
such a setting the treatment options can be reduced to thyroid hor-
mone substitution or the administration of anti-thyroid drugs for
hypo- or hyperthyroidism, respectively. The patients had shownm supplementation. Uneventful pregnancy.
AB
Fig. 8. A. SR. Hypothyroidism coupled to coenzyme Q10 deﬁciency. B: Current ultrasound image (2014) showing partial recovery of morphology.
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cause the on-going pharmacological treatment had not eliminated
all symptoms. In addition to this, the proof the concept of ourtreatment model required to have imaging material from the ﬁrst
clinical examination as well as to have follow-up examination done
with the same technology. An additional factor that limited the
Fig. 9. 3D power Doppler of a woman with hyperthyroidism. Note the thickened vascular
structures.We interpret this characteristic as an indirect sign or coenzyme Q10 deﬁciency.
In two patients with thyroiditis the implementation of supplementation did not lead to
any improvement of thyroid morphology. Both patients presented an image with
hyperechogenic structures on the hypoechogenic thyroid (10A) as well as hyperperfusion
(10B).
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mentation. Oral magnesium supplementation requires a relatively
long time. First positive results can be seen after 6–8 months. SomeFig. 10. Hyperechogenic structures on the hypoechogenic thyroid (10A) as well as hyper-
perfusion (10B) suggestive of ﬁbrosis.patients tend to stop supplementation if no improvement has been
achieved within 2–3 months.
At our private practice we include all treatment methods according
to the WOMED model from the ﬁrst visit on. Patients seek our medical
care for the same reasonmentioned above: lack of satisfactionwith con-
ventional treatment. Unfortunately the original external imagingmate-
rial is generally of very poor quality (mostly done with a 7.5 MHz
probe). If better digital images had been available we could have includ-
ed sonography material from more than 100 patients. Our strategy has
been to follow up our patients using 3D power Doppler ultrasound.
These experiences have been recently published [8]. The preliminary
use of sonography with advanced dynamic ﬂow capability appears to
offer an alternative to 3D-power Doppler. Further studies are being
done on this topic at the moment.
An additional issue that can be derived fromour study is related to the
concept of thyroid function interferingwith pregnancy [20]. Two patients
in our series went through pregnancy without any negative effects and
taking solely magnesium citrate. This issue has not been addressed by
other authors before. Our results suggest a role for magnesium in
pregnancy.
The dogmatic model of autoimmunity has been described recently
by Caturegli et al. [2]. The authors state: “The normal thyroid gland,
being composed of thyroid follicles of various dimensions, scatters the
ultrasounds signiﬁcantly so that the lobes appear bright. In HT, on the
contrary, thyroid follicles are destroyed and replaced by small lympho-
cytes so that the echogenicity of the thyroid parenchyma markedly de-
creases, becoming similar to that of the surrounding strapmuscles.”Out
results contradict this statement since a reconstitution of the morpho-
logical structure can be attained. Thus, the dogmatic model appears to
have overseen practical and simple potentials for recovery. In addition
to this we have enumerated ﬂaws in the construction of animal models
of thyroid autoimmunity recently (Section 4.8 in [8]).
Magnesium plays a role in thyroid physiology which is reﬂected by
the recovery of normal thyroid morphology. Theoretically by avoiding
a progressive deleterious change of thyroidmorphology, potential com-
plications such as malignancy should be preventable. We see the main
role of magnesium in maintaining the integrity of complex V of the ox-
idative phosphorylation chain [8]. Alteration of this physiological array
could contribute to malignant development since the metabolic path-
way of thyroid cells would no longer rely on oxidative phosphorylation
[21].
5. Conclusions
For the sake of patients with benign non-nodular thyroid disease, a
practical approach based on biochemical parameters (e.g. magnesium,
selenium, coenzyme Q10) and objective sonographical data should re-
place the obscure dogmatic model of autoimmunity.
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